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The endoplasmic reticulum-associated degradation (ERAD) pathway is responsible for disposing misfolded proteins from the
endoplasmic reticulum by inducing their ubiquitination and degradation. Ubiquitination is conventionally observed on lysine
residues and has been demonstrated on cysteine residues and protein N-termini. Ubiquitination is fundamental to the ERAD
process; however, a mutant T-cell receptor 𝛼 (TCR𝛼) lacking lysine residues is targeted for the degradation by the ERAD pathway.
We have shown that ubiquitination of lysine-less TCR𝛼 occurs on internal, non-lysine residues and that the same E3 ligase
conjugates ubiquitin to TCR𝛼 in the presence or absence of lysine residues. Mass-spectrometry indicates that WT-TCR𝛼 is
ubiquitinated on multiple lysine residues. Recent publications have provided indirect evidence that serine and threonine residues
may be modified by ubiquitin. Using a novel peptide-based stable isotope labeling in cell culture (SILAC) approach, we show
that specific lysine-less TCR𝛼 peptides become modified. In this study, we demonstrate that it is possible to detect both ester and
thioester based ubiquitination events, although the exact linkage on lysine-less TCR𝛼 remains elusive. These findings demonstrate
that SILAC can be used as a tool to identify modified peptides, even those with novel modifications that may not be detected using
conventional proteomic work flows or informatics algorithms.
1. Introduction
Approximately one-third of newly synthesized proteins are
targeted for the degradation by the proteasome within min-
utes of their synthesis as a result of premature termina-
tion or misfolding. ER-associated degradation (ERAD) is a
specialized pathway that targets misfolded nascent proteins
in the endoplasmic reticulum (ER) for degradation via the
proteasome [1]. In the ER, misfolded proteins are recognized
by several quality control mechanisms that escort them to a
channel for retrotranslocation to the cytosol. Soon after retro-
translocation, these proteins are ubiquitinated and extracted
from the ER membrane with the help of the Cdc48p/p97
complex. Ubiquitination acts as a signal to target proteins
to the proteasome and thus is an essential process in the
degradation of newly synthesized defective proteins.
Ubiquitination is a post-translational modification that
regulates many cellular events such as protein degradation,
endocytosis, and the cell cycle. The process of ubiquitination
involves the concerted action of an E1 ubiquitin-activating
enzyme, an E2 ubiquitin-conjugating enzyme, and an E3
ubiquitin ligase.The last step of ubiquitination is mediated by
an E3 ubiquitin ligase that provides specificity to the pathway
by binding both the target substrate molecule and an E2
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ubiquitin-conjugating enzyme (E2) loaded with ubiquitin.
Ubiquitin is then transferred from the E2 active site cysteine
to a lysine residue of the substrate, forming an isopeptide
bond between the substrate and ubiquitin [2].
Not all misfolded or defective proteins necessarily encode
for or contain accessible lysine residues for ubiquitination, yet
these proteins must still be degraded. Thus, it is tempting to
speculate that degradation of misfolded or defective proteins
relies on a mechanism that is not solely dependent on
lysine residues. Interestingly, it was recently reported that
proteins may be ubiquitinated on nonlysine residues. For
example,N-recognins, a particular class of E3 ligases, have the
ability to ubiquitinate the 𝛼-amino group on the N-terminus
of their substrates in order to mediate degradation [3].
More recently, viral E3 ubiquitin ligases encoded by Kaposi’s
sarcoma-associated herpes virus and its murine homologue,
MHV68, have been reported to mediate degradation of sur-
face molecules by promoting their ubiquitination on cysteine
and serine/threonine residues, respectively [4, 5]. Several
cellular proteins are also known to undergo unconventional
ubiquitination, including Pex5p, which is thought to be
ubiquitinated on serines/threonines and Bid, which is ubiq-
uitinated on cysteine residues [6, 7]. Given the large number
of cellular E3 ubiquitin ligases present (>600 identified [8]),
it is unknown whether nonlysine ubiquitination is specific to
a few highly specialized E3s or if it is a process common to
many E3s that remains thus far underappreciated. Critically
though, direct evidence of serine and threonine targeted
ubiquitination, in the form of an ester linked −GG signature
peptide (ggSP) has remained elusive.
Interestingly, a mutant form of the T-cell receptor 𝛼
subunit (TCR𝛼) that lacks lysine residues can be targeted to
the proteasome via ERAD through unknown mechanisms
[9, 10]. Both lysine and nonlysine ubiquitination of TCR𝛼
are dependent upon a functional Hrd1 E3 ligase indicating
that this E3 ligase can facilitate both lysine and nonlysine
ubiquitination. In this study, we use a novel SILAC method
coupled with LC-MS/MS to show that several peptides
near the C-terminus of lysine-less TCR𝛼 (KR-TCR𝛼) are
involved in the association between ubiquitin and KR-TCR𝛼,
in contrast to wildtype TCR𝛼 (WT-TCR𝛼), where direct
modification of lysine residues can be observed.These results
strongly suggest that in the absence of lysine residues, the
cellular protein degradation machinery has acquired the
ability to ubiquitinate nonlysine residues in order to prevent
the accumulation of defective peptides. So far, existing
bioinformatics tools have been unable to provide direct
evidence for unconventional ubiquitination. However, using
a novel SILAC approach, we have been able to determine
which specific peptide becomes modified, even though the
composition of the posttranslational modification(s) remains
unknown.
2. Materials and Methods
2.1. Cell Culture and Reagents. HEK293T cells (number CRL-
11268; American Tissue Culture Collection) were maintained
in Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum and 100 𝜇g/mL penicillin/streptomy-
cin and transfected using Fugene HD (Roche) according to
the manufacturer’s instructions. Restriction grade thrombin
(Novagen) was used according to manufacturer’s instruc-
tions. PNGase F (NEB) digestions were carried out according
to the manufacturer’s instructions. Cycloheximide (Sigma)
was used at 100 𝜇g/mL for 0, 1, or 2 hours prior to lysis.
2.2. Plasmids. pCDNA3.1 vectors expressing an HA tagged
version of WT-TCR𝛼 and KR-TCR𝛼 were gifts from Dr. Ron
Kopito (Stanford University). pCDNA3.1 vectors expressing
an myc tagged version of either wildtype Hrd1-mycHis or
a dominant negative form of Hrd1 (C240A-) mycHis were
gifts from Dr. Emmanuel Wiertz (Leiden University Med-
ical Center, Netherlands). The NE (Neutrophil elastase)
construct was provided by Dr. Marshall Horowitz (Uni-
versity of Washington, Seattle, WA) and subcloned into
pCDNA3.1 using BamHI and XhoI restriction sites. MSCV
HA-HLA-A2 was provided by Dr. Kathleen Collins (Uni-
versity of Michigan Medical School). The HSV-epitope tag
(QPELAPEDPED) was inserted downstream of the TCR𝛼
signal sequence (MQRNLGAVLGIL) using overlap PCR.The
thrombin cleavage site (LVPRGS) was cloned downstream
of the HSV-epitope tag using a similar method. Threonine
262 and Serine 267/268 mutations to alanine and modified
HA tags (YPYDVPDYASL → YPYDVPDYAL) were cloned
using PCR site-directed mutagenesis.
2.3. Immunoprecipitation, Western Blot Analysis and Anti-
bodies. Cells were transfected 48 hrs prior to cell lysis. Cells
were treated with 10 𝜇M MG132 (unless otherwise noted)
for 3 hrs and then lysed in RIPA lysis buffer (50mM Tris-
HCl pH 8, 150mM NaCl, 1% Nonidet P40, 0.5% Sodium
Deoxycholate, and 0.1% SDS) supplemented with protease
inhibitor cocktail EDTA-free (Roche). Cellular lysates were
quantified using the BCAProteinAssay kit (Pierce) according
to the manufacturer’s protocol. For immunoprecipitation,
1mg of protein was incubated with 1 𝜇g of anti-HA (Santa
Cruz Biotech) antibody and 30 𝜇L protein A/G agarose beads
(Santa Cruz Biotech) overnight. Samples were separated on
12% polyacrylamide gels and transferred to PVDF mem-
brane. Blots were probed with either anti-HA (Santa Cruz
Biotech), anti-𝛽-actin (Abcam), anti-ubiquitin P4D1 (Santa
Cruz Biotech), anti-His (Santa Cruz Biotech), or anti-HSV
(Genscript Corp.). For double immunoprecipitation, samples
were reimmunoprecipitated with 25𝜇L anti-HSV agarose
overnight in RIPA lysis buffer.
Reverse Transcription Quantitative Real-Time PCR (RT-
qPCR). 293T were transfected with siRNA against Hrd1 (ON-
TARGETplus SMARTpool Human SYVN1, Dharmacon) or
a negative control siRNA (AllStars Neg. Control siRNA,
Qiagen) using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. 24 hours posttransfection,
RNA was extracted in Trizol (Invitrogen), treated with RQ1
DNase (Promega), and total RNA was reverse transcribed
using oligo (dT) 15 primer (Promega) and SuperScriptII
(Invitrogen) at 42∘C for 50 minutes. cDNAs were extracted
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to analyze levels of GAPDH and Hrd1 mRNA using ABI7300
Real-Time PCR System.
2.4. AlkalineHydrolysis. Cells were transfected 48 hrs prior to
hydrolysis. Cells were incubated with 10 𝜇MMG132 for 3 hrs
and then washed 3 times with 10mL PBS, once with 10mL
of 100mM NaCl and then resuspended in 100mM Na
2
CO
3
pH 11.5. Samples were dounced 10 times in a 2mL glass
dounce homogenizer (tight pestle) and then incubated on ice
for 30min. Samples were then ultracentrifuged (TLA100.2
rotor, 60min, 68K rpm, 4∘C). Membrane fractions were
recombined with soluble fractions and added to 2X RIPA
plus protease inhibitor cocktail. Samples were quantified and
immunoprecipitated with the same protocol listed above.
2.5. SILAC/Mass Spectrometry. HEK293T cells were cultured
in SILAC DMEM (Pierce) lacking lysine and arginine that
was supplemented with isotopically enriched forms of L-
Leucine (13C
6
, 50𝜇g/mL), (L-lysine (13C
6
, 15N
2
hydrochlo-
ride; 50𝜇g/mL), and L-arginine (13C
6
, 15N
4
hydrochloride;
40 𝜇g/mL) (heavy) or the corresponding unlabeled form of
each at the same concentration (light). Both heavy and light
forms of DMEM were further supplemented with L-proline
(200𝜇g/mL; to preventmetabolic conversion of Arg → Pro),
L-glutamine (2mM), and 10% dialyzed FBS (Pierce). After
5 days of metabolic labeling, cells were transfected with the
denoted constructs and allowed to express the constructs
for 48 hr prior to treatment with MG132 (10 𝜇M, 3 hr). Cells
were lysed in RIPA buffer and immunoprecipitated with 2𝜇g
anti-HA antibody and 50 𝜇L protein A/G agarose beads for
3 hours. Immunoprecipitations were washed and TCR𝛼 was
eluted using 30 𝜇L HA peptide (1mg/mL in TBS) for 30min
at room temperature. Elutions were transferred to clean
tubes and digested with PNGase F (New England Biolabs)
according to the manufacturer’s instructions. Samples were
separated by SDS-PAGE and then stained with Simply Blue
Coomassie stain (Invitrogen) according to themanufacturer’s
instructions. Regions of the gel containing unmodified TCR𝛼
(low molecular weight) and modified TCR𝛼 (high molecular
weight) were excised and diced into 1mm cubes. Proteins
were subjected to overnight in gel trypsin digestion in the
presence of 10 ng/𝜇L trypsin resuspended in 50mM ammo-
nium bicarbonate/5% acetonitrile. Peptides were extracted
with 50% acetonitrile/5% formic acid and then dried to com-
pletion, resuspended in 4%acetonitrile/5% formic acid/0.01%
hydrogen peroxide and then heavy and light samples were
combined for analysis.
For LC-MS/MS analysis, samples were analyzed on an
LTQ-Orbitrap XL (ThermoFisher, San Jose, CA) with
an ADVANCE electrospray ionization source (Michrom,
Auburn, CA). Peptides were loaded onto a 0.1mm × 100mm
waters 1.7 𝜇m BEH-130 C18 column for 10min and sepa-
rated at 1.0 𝜇L/min by a gradient where solvent B (98%
acetonitrile/0.1% formic acid) was ramped from 5% to 25%
over 35min and then from 25% to 50% over 2min. The
mass spectrometer was operated such that a duty cycle was
comprised of one full MS scan collected at 60000 resolution
in the Orbitrap and eight MS/MS scans in the ion trap. For
targeted analysis, four of the eight scan events were devoted
to ions corresponding to ggSP from KR-TCR𝛼. Quantitative
data was manually interrogated using QualBrowser v2.07
(ThermoFisher). For peptide identification, MS/MS spectra
were searched using Mascot against a concatenated target-
decoy database comprised of human protein sequences,
known contaminants, TCR𝛼 sequences of interest, and the
reversed versions of each with a 50 ppm precursor ion toler-
ance and 0.8Da fragment ion tolerant. Variablemodifications
were permitted for methionine oxidation (+15.9949Da) and
ubiquitin di-glycine remnant (−GG signature) on lysine,
cysteine, serine, or threonine (+114.0429Da). No more than
three variablemodifications were permitted in a given search.
Precursor ion mass accuracy was used as an orthogonal filter
prior to manual inspection of peptide spectral matches.
2.6. In Vitro Ubiquitination of UbcH5c (E2 Charge Assay).
Reactions (15 𝜇L) of an E2-ubiquitin thioester (or ester for
DN) were carried out by combining 0.028𝜇M E1, 0.5–10𝜇M
E2 (UbcH5c or UbcH5c-DN), and 0.2 𝜇M ubiquitin in a
buffer (50mMTris-HCl, pH 7.5, 50mMNaCl, 5mMMgSO
4
,
and 5mM ATP) and incubated for 30min at 37∘C. Samples
were boiled for 5min and separated by SDS-PAGE and
stained with Coomassie Blue prior to the analysis by mass
spectrometry.
3. Results
3.1. KR-TCR𝛼 Is Ubiquitinated and Degraded by the Pro-
teasome. In order to understand the molecular mechanism
allowing for lysine-less proteins to be targeted by the ERAD
pathway, we employed KR-TCR𝛼 as a substrate. TCR𝛼 is an
ideal candidate protein to study ERADbecause in non-T cells,
TCR𝛼 lacks binding partners like CD3 and TCR𝛽, and there-
fore the vast majority is misfolded and targeted through the
ERAD pathway. HEK293T cells were transiently transfected
with an empty vector control, a vector encoding HA-tagged
WT-TCR𝛼 orHA-taggedmutant TCR𝛼 (KR-TCR𝛼) in which
all available lysines were mutated to arginines. Cells were
either untreated or treated for 3 hours with the proteasome
inhibitor MG132. Cellular lysates were subjected to immuno-
precipitation using an anti-HA antibody, and the presence
of ubiquitinated TCR𝛼 was examined by the Western blot
analysis. As shown in Figure 1(a),MG132 treatment increased
the level of polyubiquitination on both WT-TCR𝛼 and KR-
TCR𝛼 compared to untreated samples.
To verify the specificity of the anti-ubiquitin antibody,
HEK293T cells were cotransfected with a vector encoding
6XHis-tagged ubiquitin (6XHis-Ub) together with a vector
containing HA-tagged WT-TCR𝛼 or KR-TCR𝛼. Cellular
lysates were immunoprecipitated with an anti-HA antibody,
and 6XHis-ubiquitin incorporation into high molecular
weight species of TCR𝛼 was visualized by Western blot
using an anti-His antibody. Figure 1(b) shows that 6xHis-
Ubiquitin is indeed incorporated into both WT-TCR𝛼 and
KR-TCR𝛼 high molecular weight species indicating that
both are extensively poly-ubiquitinated. Western blots were
stripped and reprobed with an anti-HA antibody to verify
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Figure 1: KR-TCR𝛼 is ubiquitinated and degraded by the proteasome. (a)HEK293T cells were transfectedwith a vector expressingWT-TCR𝛼,
or a vector expressing KR-TCR𝛼. Cells were either untreated or incubated withMG132 before lysis. Cellular lysates were immunoprecipitated
using an anti-HA antibody and the ubiquitination status of TCR𝛼 was analyzed by Western blot analysis using an anti-ubiquitin antibody
(top panel). Membranes were stripped and reanalyzed using an anti-HA antibody (bottom panel). (b) HEK293T cells were cotransfected with
6XHis-Ub and either a vector expressingWT-TCR𝛼 or KR-TCR𝛼. Cells were either untreated or incubated with MG132 before lysis. Cellular
lysates were immunoprecipitated using an anti-HA antibody and the ubiquitination status of TCR𝛼 was analyzed by Western blot analysis
using an anti-His antibody (top panel). Membranes were stripped and reanalyzed using an anti-HA antibody (bottom panel). Molecular
weight markers (kD) of marker proteins are indicated.
all constructs were expressed at comparable levels (Figures
1(a) and 1(b)). MG132 treatment revealed an additional low
molecular weight species which has been shown to represent
a deglycosylated version of TCR𝛼 that has been extracted
from the ER membrane [11]. In the absence of MG132,
deglycosylated TCR𝛼 is rapidly degraded. The observed
stabilization of deglycosylated KR-TCR𝛼 by MG132 strongly
suggests that similar to WT-TCR𝛼, KR-TCR𝛼 is degraded in
a proteasome-dependent manner.
It is possible that the high molecular weight ubiquitin
signal observed could represent an unknown KR-TCR𝛼-
associated cofactor that is ubiquitinated and required for
targeting of KR-TCR𝛼 to the proteasome. In order to address
the possibility that the observed signal may be due to
ubiquitination of a sacrificial protein that coimmunoprecip-
itates with TCR𝛼, we performed a double immunoprecip-
itation experiment. Figure S1 shows that even after TCR𝛼
immunoprecipitations have been completely denatured and
reimmunoprecipitated (Supplementary Figures are avail-
able online at http://dx.doi.org/10.1155/2013/857918); we still
observe robust ubiquitination of both WT-TCR𝛼 and KR-
TCR𝛼. This result suggests that both proteins are physically
associated with ubiquitin and, consequently, that KR-TCR𝛼
is directly ubiquitinated.
N-terminal ubiquitination has been described for several
proteins and is lysine-independent. To determine whether
International Journal of Proteomics 5
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Figure 2: Degradation of WT-TCR𝛼 and KR-TCR𝛼 is dependent upon the E3 ubiquitin ligase Hrd1. (a) The various TCR𝛼 constructs were
cotransfectedwithWT-Hrd1 orDN-Hrd1. Transfected cells were incubatedwithMG132 before lysis. Cellular lysateswere immunoprecipitated
with an anti-HA antibody and analyzed byWestern blot using an anti-HA antibody. (b) 293Twere cotransfected with a SMARTPool of siRNA
against Hrd1 or negative control siRNA and vector, WT-TCR𝛼, or KR-TCR𝛼 (HA-tagged). 24 hrs posttransfection, cells were treated with
MG132 and lysed and levels of TCR𝛼 were determined by Western blotting with an anti-HA antibody. Levels of Hrd1 were determined by
qRT-PCR.
KR-TCR𝛼 is ubiquitinated on its N-terminus, an HSV tag
followed by a thrombin cleavage site (TMB) was introduced
downstream of the TCR𝛼 signal peptide in the WT-TCR𝛼
or KR-TCR𝛼 backbone (Figure S2A). Cellular lysates were
immunoprecipitated with an anti-HA antibody, and the
resulting immunoprecipitates were digested with thrombin
and washed extensively to eliminate N-terminal peptides. As
shown in Figure S2B, ubiquitination was readily detectable
with the various TCR𝛼 constructs, regardless of whether the
N-terminus was present. These results are consistent with
ubiquitination of KR-TCR𝛼 on internal, nonlysine residues.
3.2. The E3 Ubiquitin Ligase Hrd1 Is Involved in the Ubiquiti-
nation of Both WT-TCR𝛼 and KR-TCR𝛼. Ubiquitination of
WT-TCR𝛼 is known to require Hrd1 [12, 13], an E3 ubiquitin
ligase of the RING finger family that mediates degradation
of many ER substrates [1]. To determine whether Hrd1 is
also required for the degradation of KR-TCR𝛼, HEK293T
cells were cotransfected with expression vectors for the
different TCR𝛼 constructs together with vectors encoding
wildtype Hrd1 (Hrd1-WT) or a dominant negative version of
Hrd1 (Hrd1-DN) [12]. Degradation of TCR𝛼 was assessed by
Western blot analysis. As shown in Figure 2(a), the expression
of Hrd1-DN is associated with an accumulation of the
glycosylated form and a decrease in the deglycosylated form
of bothWT-TCR𝛼 andKR-TCR𝛼. By contrast, the expression
ofHrd1-WT led to a complete loss of the glycosylated forms of
both WT-TCR𝛼 and KR-TCR𝛼. Additionally, siRNA knock-
down of Hrd1 led to an accumulation of glycosylated forms
of both WT-TCR𝛼 and KR-TCR𝛼 (Figure 2(b)) relative to a
nontargeting control siRNA.Altogether, these results indicate
that Hrd1mediates KR-TCR𝛼 retrotranslocation and strongly
suggest that Hrd1 is the E3 ubiquitin ligase responsible for
degradation of both WT-TCR𝛼 and KR-TCR𝛼. These results
are in agreement with recent data showing that Hrd1 is also
required for ubiquitination of a lysine-less version of NS-1,
another model ERAD substrate [13].
3.3. KR-TCR𝛼 Ubiquitination Is Partially Sensitive to Mild
Alkaline Hydrolysis. Ubiquitination on cysteine, serine, and
threonine residues has recently been reported [4–7, 13,
14]. Cysteine ubiquitination involves the formation of
thioester bonds, which are sensitive to reducing conditions.
Because experiments illustrated in Figures 1, S1, and S2
were performed in the presence of the reducing agent 𝛽2-
mercaptoethanol, it is unlikely that cysteine ubiquitination
is contributing to the ubiquitin signal observed on KR-
TCR𝛼. Ubiquitination of serine and threonine residueswould
presumably occur via ester bonds that are not reduced under
standard denaturing conditions, but would be susceptible to
mild alkaline hydrolysis. Alkaline hydrolysis treatment does
not affect isopeptide bonds, which are formed by ubiquitina-
tion of lysine residues. To test if KR-TCR𝛼 associated ubiq-
uitin may reside on serine or threonine residues, HEK293T
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cells were transiently transfected withWT-TCR𝛼, KR-TCR𝛼,
or a vector control and were treated with MG132 to allow
for the accumulation of ubiquitinated TCR𝛼 proteins. Cells
were then lysed and subjected to mild alkaline hydrolysis for
two hours. Cellular lysates were immunoprecipitated using
an anti-HA antibody and analyzed by Western blot using
an anti-ubiquitin antibody. The level of ubiquitination in
hydrolyzed samples was quantified relative to unhydrolyzed
samples using densitometry (Figure S3B). Interestingly, ubiq-
uitination ofWT-TCR𝛼 is not sensitive to alkaline hydrolysis,
which suggests that when lysine residues are present, they are
the preferred targets of ubiquitin. By contrast, ubiquitination
of KR-TCR𝛼 is partially diminished upon mild alkaline
treatment (Figure S3A), despite the quantity of unmodified
TCR𝛼 being similar in all samples (Figure S3B). This level
of hydrolysis is in accordance with what other reports have
demonstrated for serine/threonine ubiquitination [5, 7, 13].
Harsher alkaline treatments were investigated; however, this
led to degradation of the unmodified protein for both
WT-TCR𝛼 and KR-TCR𝛼 (data not shown). Presumably, if
ubiquitination on KR-TCR𝛼 was solely attached via an ester
linkage, mild alkaline treatment should lead to complete
hydrolysis of this bond. This result suggests that KR-TCR𝛼
may be ubiquitinated on nonlysine residues via ester linkages
in addition to other unknown linkages, or by a linkage that is
only partially susceptible to alkaline hydrolysis.
3.4. WT-TCR𝛼 Is Ubiquitinated on Lys-118, -144, and -178. To
determine which residues on WT-TCR𝛼 could be modified
by ubiquitin, samples containing ubiquitinated WT-TCR𝛼
were subjected to LC-MS/MS analysis. HEK293T cells were
transfected with TCR𝛼 or vector alone, incubated with
MG132 and then lysed. Lysates were subjected to immunopre-
cipitation with an anti-HA antibody and examined by SDS-
PAGE followed by Coomassie Blue staining (Figure 3(a)).
Four separate regions (labeled 1–4, Figure 3(a)) were excised
for each sample and subjected to in-gel trypsin digestion.
Trypsinization of an ubiquitinated protein yields a diglycine
signature as a remnant at the position where ubiquitin
was bound and results in a mass increase of 114.0429Da
on ggSP. Samples were analyzed by LC-MS/MS, and the
resulting spectra searched for ggSP using the Mascot search
algorithm. Of the twelve lysine-containing peptides of WT-
TCR𝛼, ubiquitination of Lys-118, Lys-144, and Lys-178 were
detected (Figures 3(c)–3(e)). Data collected from digested
WT-TCR𝛼 samples were subsequently searched for the pres-
ence of ggSP where serine/threonine modifications were
permitted, but none were identified. This data supports the
hypothesis that when lysines are accessible, they are the
preferred sites of ubiquitination. Similar LC-MS/MS analyses
were also performed in an attempt to ascertain the sites of
ubiquitination onKR-TCR𝛼. Database searches for ggSPwith
modification of serine/threonine residues again did not yield
any modified peptide spectral matches.
3.5. Novel SILAC Method Indicates That KR-TCR𝛼 Is Directly
Modified on the Peptide VAGFNLLMTLR. There are twenty-
eight serine residues and twenty-five threonine residues
present in KR-TCR𝛼. Because such a substantial portion of
KR-TCR𝛼 is composed of serine or threonine residues, com-
binatorial mutagenesis of these residues would most likely
prevent entry into the ER which may cause unpredictable
changes in the mechanisms of degradation. Therefore, we
used stable isotope labeling in cell culture coupled with
tandemmass spectrometry (SILAC-MS) to generate evidence
for ubiquitin modification on Ser/Thr residues of KR-TCR𝛼.
Theoretically, the unmodified versions of ubiquitin-modified
peptides would be diminished in high molecular weight
forms of Ub-KR-TCR𝛼 relative to unmodified KR-TCR𝛼.
HEK293T cells were cultured in media supplemented with
either the heavy (13C
6
,15N
2
-Lys, 13C
6
,15N
4
-Arg, 13C
6
-Leu) or
light forms of lysine, arginine, and leucine and subsequently
transfected with either empty vector or a vector expressing
KR-TCR𝛼. Cells were treated with MG132, lysed, and then
subjected to separate immunoprecipitations with an anti-
HA antibody. The unmodified and Ub-KR-TCR𝛼 in each
immunoprecipitation were separated by SDS-PAGE in indi-
vidual lanes, then stained with Coomassie Blue. Gel regions
containing isotopically light, Ub-KR-TCR𝛼 (high molecular
weight) and isotopically heavy, unmodified KR-TCR𝛼 (low
molecular weight) were excised as separate gel bands and
digested (Figure 4(a)). After extracting tryptic peptides, a
portion of the low molecular weight unmodified KR-TCR𝛼
(heavy) sample was mixed with peptides from the high
molecular weight gel piece containing Ub-KR-TCR𝛼 (light).
LC-MS/MS analysis was performed to determine the relative
abundance of heavy and light peptides, with the prediction
that heavy to light ratios would be consistent for peptides
derived from unmodified regions of sequence. Alternatively,
the modification of a residue by ubiquitin would decrease
the relative abundance of the corresponding unmodified
peptide in the high molecular weight (ubiquitinated) sample
relative to its unmodified counterpart in the low molecular
weight region. Peptides from the N-terminal portion of the
protein were identified and found to have consistent ratios
between high and lowmolecularweight regions.However, for
peptides in the C-terminal portion of the protein, a marked
decrease was observed in the high molecular weight region.
This was particularly apparent for peptides SFETDMNLN-
FQNLSVMGLR (aa 230–248), VAGFNLLMTLR (aa 254–
264), and LWSSYPYDVPDYAL (aa 265–279) (Table 1 and
Figure 4(b)). This result suggests that modifications occur-
ring on residues within these sequences are decreasing the
abundance of the corresponding peptides. Notably, each of
these peptides contains at least one Ser or Thr residue. It is
important to note that since we are using a C-terminalHA tag
to immunoprecipitate these proteins, these peptides are not
dropping out of the high molecular weight fraction because
of C-terminal degradation or incomplete translation.
Multiple approaches were carried out in an attempt to
match a spectrum from the ubiquitin modified sequences.
Neither error tolerant searches in Mascot nor the InsPecT
algorithm [15] yielded a hint as to the nature of the mod-
ification. Next we carried out targeted LC-MS/MS analysis
on the peptide VAGFNLLMTLR (residues 254–264) in hopes
of generating a direct evidence of a ggSP in this region.
The VAGFNLLMTLR peptide is ideally suited for targeted
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Figure 3: Tandem mass-spectrometry identification of −GG signature peptides from ubiquitinated TCR𝛼 on Lys-118, Lys-144, and Lys-178.
HEK293T cells were transiently transfected with WT-TCR𝛼 or vector alone, incubated with MG132, and then lysed. Lysates were subjected
to immunoprecipitation with an anti-HA antibody and examined by SDS-PAGE followed by Coomassie staining. Four regions of the gel
were excised and trypsinized as shown in (a). Samples were analyzed by tandem mass-spectrometry and the results are summarized in (b).
Peptide spectral matches to −GG signature peptides (ggSP) at Lys-118, Lys-144, or Lys-178 in each region of the gel are indicated by red
shading. Representative MS/MS spectra for each of the ggSP are shown: (c) Lys-118, (d) Lys-144, and (e) Lys-178. The peaks are labeled with
the fragment ion and its charge state. For example, y14-1 is the singly charged version of y14. b- and y-fragment ions are denoted by blue and
red, respectively. Green squares denote precursor ions, multiply charged fragment ions, or predictable neutral loss ions accounted for during
manual inspection of MS/MS data.
analysis because it contains a single threonine residue, no
serine residues, and showed decreased relative abundance
in ubiquitin modified KR-TCR𝛼. In the VAGNLLMTLR
peptide, it was presumed that the decreased SILAC ratio of
unmodifiedVAGNLLMTLR should coincide with the forma-
tion of an ester-linked ggSP ofThr-262. FocusedMS/MS scan
events targeting the unmodified and ubiquitinmodified form
of this sequence (+114.0429Da) were established towards
ions in multiple charge states (𝑧 = 2, 𝑧 = 3). To ensure
that methionine oxidation did not confound the analysis,
methionine residues were converted into the methionine-
sulfoxide formusing an optimized hydrogen peroxide/formic
acid incubation method recently optimized in our lab [16].
Surprisingly, no spectra were identified as matching to an
ester-linked ggSP for the sequence covering Thr-262. To
determine if a serine in place of Thr-262 could facilitate
dropout of the unmodified peptide signal from the high
molecular weight fraction, we mutated Thr-262 to a serine.
While KR-TCR𝛼-T262S could facilitate dropout from the
high molecular weight region, again, no ester-linked ggSP
were observed in the targeted analyses (data not shown).
Sincewewere unable to generate direct evidence for ester-
linked ggSP on VAGNLLMTLR, we next tried to determine
ifThr-262 is required for dropout of signal of the unmodified
version in the high molecular weight fraction of the gel. Thr-
262 mutation to an alanine eliminates the possibility of form-
ing an ester-linked ubiquitin. SILAC labeled HEK293T cells
transfected with vectors expressing KR-TCR𝛼 or KR-TCR𝛼-
T262A were prepared as above. A bar graph representing the
relative abundance of the VAGNLLMTLR peptide and five
additional KR-TCR𝛼 peptides are shown in Figure 4(c) to
allow comparison of peptides in the high molecular weight
gel region B (red) against the same peptides from the low
molecular weight, unmodified TCR𝛼 band (blue). Mutation
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Figure 4: KR-TCR𝛼 peptide VAGFNLLMTLR (aa 254–264) is modified. HEK293T cells were incubated in either heavy or light SILAC
media for five days and then transiently transfected with KR-TCR𝛼 or vector alone, incubated with MG132 and then lysed. Lysates were
subjected to immunoprecipitation with an anti-HA antibody and examined by SDS-PAGE followed by Coomassie staining. (a) Gel pieces
containing heavy, unmodified TCR𝛼 were combined with gel pieces containing light SILAC labeled, ubiquitin-modified KR-TCR𝛼. Heavy
and light proteins were digested with trypsin and analyzed by LC-MS/MS. (b) Seven narrow range full-MS spectra for representative KR-
TCR𝛼 peptides are shown. Data were collected in high-resolution on an LTQ-Orbitrap, with light ions shown in red and heavy ions in blue.
(c) HEK293T cells were incubated in either heavy or light SILAC media for five days, transfected with KR-TCR𝛼 or KR-TCR𝛼-T262A, and
the same experimental procedure was followed as in Table 1. The relative abundance of six peptides are quantified and represented in the bar
graph. Numbers represent the area under the curve for the peptide in the high molecular weight region (corresponding to modified TCR𝛼)
divided by the peak height of the same peptide in the low molecular weight region (corresponding to unmodified TCR𝛼).
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of Thr 262 to an alanine partially reversed the negative log 2
light/heavy ratio for the peptide VAGFNLLMAR relative to
its threonine-containing equivalent, suggesting that in the
absence of a threonine (Figure 4(c)), this peptide cannot
be modified. Notably though, the T262A mutation did not
completely reverse the heavy to light ratio of this peptide
relative to peptides from other portions of the sequence.
One potential explanationmay be that ubiquitinmodification
of the flanking peptides directly downstream of VAGFN-
LLMTLR impairs the ability of trypsin to liberate unmodified
VAGFNLLMTLR peptide from the TCR𝛼 sequence. Alter-
natively, additional posttranslational modifications on this
peptide could be preventing positive identification.
3.6. Evidence That Ester-Linked and Thioester-Linked Ubiqui-
tin Can Be Detected Using Traditional LC-MS/MS Methods.
One possible explanation for our inability to identify ggSP
on serine, threonine, or cysteine containing peptides could
be that our methods of sample preparation followed by
LC-MS/MS are too harsh to preserve a thioester or ester
bond. In order to determine if this was indeed problematic,
we employed an E2 charge assay to conjugate ubiquitin
to the E2 ubiquitin conjugation enzyme UbcH5c in vitro.
Either wildtype UbcH5c or a mutant version (UbcH5c-CS)
that has the catalytic cysteine (Cys-85) mutated to a serine
was used in the assay. In vitro, Ser-85 of UbcH5c-CS will
accept ubiquitin and has been used in structural studies to
permit the crystallization of an E2 charged with ubiquitin
[17]. E2 charge assay reactions were separated by SDS-PAGE
and stained with Coomassie Blue. Bands corresponding to
charged (ubiquitinated) forms of UbcH5c were excised and
subjected to in-gel trypsinization followed by LC-MS/MS
(Figure 5(a)). Figures 5(b) and 5(c) show that both thioester-
and ester-linked ubiquitin can be detected quite well by
our mass spectrometer and also withstands standard LC-
MS/MS sample preparation methods. Based on this finding,
we conclude that if ubiquitin were linked to KR-TCR𝛼 via an
ester or thioester linkage, we can deliver a suitable peptide to
the mass spectrometer for identification.
3.7. An Endogenous Protein Naturally Devoid of Lysine Resi-
dues Is Ubiquitinated and Degraded in a Proteasome-Depend-
ent Manner. An analysis of the annotated human proteome
revealed roughly a dozen validated proteins that are naturally
devoid of lysines. One protein, neutrophil elastase (NE), was
of particular interest becausemutations known to exist within
the human population lead to severe congenital neutropenia
(SCN). Interestingly, these mutations have been shown to
induce the unfolded protein response (UPR) and the level
of UPR activation is correlated with the clinical phenotype
[18]. HEK293T cells were transiently transfected with a
vector control, an HA-tagged version of NE, or an HA-
tagged version of HLA-A2, a class I major histocompatibility
(MHC-I) molecule, as a control. The ubiquitination status
of NE and HLA-A2 was analyzed by Western blot analysis.
As shown in the top panel of Figure S4, treatment with
MG132 resulted in an accumulation of polyubiquitinated NE,
but not HLA-A2, even though both proteins are expressed
at similar levels in cellular lysates (Figure S4, bottom panel).
This result suggests that NE is ubiquitinated and degraded
in a proteasome-dependent manner despite lacking lysine
residues. Endogenous proteins are likely undergoing the same
posttranslational modifications as KR-TCR𝛼; therefore, it is
imperative that we better understand this process.
4. Discussion
In this study, we have shown that a lysine-less substrate
of ERAD is directly ubiquitinated and degraded in a pro-
teasome-dependent manner. This ubiquitination is partially
sensitive to mild-alkaline hydrolysis, consistent with the
possibility that ubiquitin is attached to serine and threo-
nine residues. Although traditionally used to detect global
changes in protein expression, we employed SILAC to iden-
tify regions of a single protein that are posttranslationally
modified (Figure 4(a)). Using this approach, we show that
unmodified forms of the KR-TCR𝛼 peptides SFETDMNL-
NFQNLSVMGLR (aa 230–248), VAGFNLLMTLR (aa 254–
264), and LWSSYPYDVPDYAL (aa 265–279) are depleted
relative to other KR-TCR𝛼 peptides in highmolecular weight
Ub-KR-TCR𝛼. With only a single Thr residue, and no Lys,
Cys, or Ser, it suggests that Thr-262 within VAGFNLLMTLR
may indeed carry ubiquitin. In a sample where lysine residues
are available for ubiquitin modification, we observe thatWT-
TCR𝛼 is directly ubiquitinated on at least three lysine residues
within the ectodomain, supporting previous studies which
suggest that lysine residues are preferred over nonlysine
residues [19]. Our data support a model in which the cellular
protein degradation machinery has evolved to ubiquitinate
nonlysine residues in cases where lysine residues may not
be available, as a means to prevent the accumulation of
misfolded or defective proteins.
The existence of alternative modes of ubiquitination in
these cellular processes may be essential to ensure the degra-
dation of a highly diverse array of substrates. In support of
this, we have shown that the endogenous protein NE, which
lacks lysine residues, can also be ubiquitinated and degraded
in a proteasome-dependent manner. Although ERAD and
cellular quality control systems are highly efficient at elim-
inating misfolded proteins, the accumulation of defective
proteins is observed in numerous diseases such as cystic
fibrosis or Parkinson’s disease [20]. Similarly, humans that
carry genetic mutations in NE develop SCN which is char-
acterized by recurrent bacterial infections and predisposes
patients to myelodysplasia and acute myelogenous leukemia
[21]. Interestingly, these same genetic mutations in NE have
been shown to activate the unfolded protein response and
lead to cellular apoptosis [18].Therefore, it is essential that we
better understand the cellular pathways involved in attaching
and removing this modification as well as defining its exact
chemical composition.
Ubiquitination of substrates has long been thought to
occur exclusively through amine groups on lysine residues or
the N-terminus of a protein. Recent reports that lysine-less
substrates can be ubiquitinated on cysteine, serine, or threo-
nine residues were unexpected. Because such modifications
have been observed in only a discrete number of substrates,
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Table 1: The normalized light to heavy ratios, denoting the relative abundance of selected peptides, between high molecular weight regions
of the gel (HMW: containing light ubiquitin-modified KR-TCR𝛼) and low-molecular weight regions of the gel (LMW: containing heavy
unmodified KR-TCR𝛼). These results are representative of two independent experiments.
KR-TCRa peptides log 2 (HMW/LMW)
R.GDQVEQSPSALSLHEGTGSALR.C 1.009
R.AVQWFQQNSR.G 0.388
R.LTFGQGTVLSVIPDIQNPEPAVYQLR.D 0.242
R.ESYSTLHIR.D 0.087
R.TVLDM∧R.A 0.074
R.TM∧ESGTFITDR.T 0.008
R.SFETDM∧NLNFQNLSVM∧GLR.I −0.536
R.LWSSYPYDVPDYAL.- −0.618
R.VAGFNLLM∧TLR.L −0.780
∧
Indicates oxidized methionine.
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Figure 5: Tandem mass-spectrometry identification of −GG signature on active site serine based on peptide spectral matches from multiple
charge states. In vitro E2 charging assays were performed on wildtype UbcH5c or C85S-mutant UbcH5c where the catalytic cysteine has
been mutated to a serine residue to stabilize its interaction with bound ubiquitin. Ubiquitin-UbcH5c thioester (wildtype) and ester linked
ubiquitin-C85S-UbcH5c (CS) were separated by SDS-PAGE and stained with Coomassie Blue (a). Regions denoted in red were excised from
the gel, digested, and analyzed by LC-MS/MS. Peptide spectral matches for serine linked ggSP were identified for UbcH5c wild type (b) and
for C85S-UbcH5c (c). Representative MS/MS spectra for several charge states are shown: 𝑧 = 3 (right panel) and 𝑧 = 4 (left panel). b- and
y-fragment ions are denoted by blue and red, respectively. Green squares denote precursor ions, multiply charged fragment ions or predictable
neutral loss ions accounted for during the manual inspection of MS/MS data.
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one could argue that lysine-independent ubiquitination is
restricted to a few specialized E3 ligases and a limited
number of substrates. Here we show that lysine-independent
ubiquitination can occur during ERAD, a process aimed at
broadly targeting defective polypeptides within the secretory
pathway. This supports a recent report by Shimizu et al. that
shows the targeting of NS-1 for ERAD by nonlysine ubiqui-
tination. In the case of NS-1, it was proposed that serine and
threonine residues mediate ubiquitin-dependent proteolysis
even though the protein contains lysine residues [13]. In our
system, we observe that when present, lysines residues are the
preferred targets of Hrd1-mediated ubiquitination, while in
the absence of lysine residues, Hrd1 is capable of conjugating
ubiquitin to nonlysine residues. Perhaps NS-1 and TCR𝛼
utilize different ERAD components that influence which
residues are accessible for ubiquitination. Future studies will
determine the regulators of lysine residue accessibility and
whether other factors are involved in catalyzing the transfer of
ubiquitin to nonlysine residues. It is also possible that a large
number of E3 ligases have the potential to performboth lysine
and lysine-independent ubiquitination and that amechanism
for the latter has been perhaps unappreciated due to the
preponderance of ubiquitination on lysine residues. One
lingering concern though is that despite multiple published
reports suggesting ubiquitination on Ser and Thr residues,
including the current work, direct MS/MS evidence of this
phenomenon in the form of a ggSP is lacking.This absence of
evidence is conspicuous given that careful studies looking for
ggSPwithmodified Ser/Thr residues have been performed by
us and others [13]. Furthermore, we show here that peptides
bearing a −GG signature on Ser can be identified and easily
detected by traditional LC-MS/MS approaches (Figure 5).
In ERAD, the protein region ubiquitinated varies depend-
ing on the substrate and the E3 ubiquitin ligase involved.MK3
is a virally encoded E3 ligase that targets MHC-I proteins
for the degradation from the ER. Recent data indicate that
ubiquitination of the intracytoplasmic domain of MHC-I on
either lysine, serine, or threonine is essential for this process
[5]. The only residues present in or proximal to the intra-
cytoplasmic domain of KR-TCR𝛼 that may act as primary
ubiquitination sites are Thr-262, Ser-267, and Ser-268. A
triple mutant of KR-TCR𝛼 where Thr-262, Ser-267, and Ser-
268 have all been mutated to alanines was also found to be
ubiquitinated to the same extent as KR-TCR𝛼 (Figure S5).
Additionally, targeted analysis focusing on ggSP for these
three Ser/Thr in KR-TCR𝛼 did not yield any peptide spectral
matches. Since these residues are unnecessary for KR-TCR𝛼
ubiquitination, our data suggest that perhaps in the absence
of these residues, the luminal and transmembrane domains
can serve as sites of ubiquitination for KR-TCR𝛼. This result
demonstrates that the ERADmachinery is quite versatile and
given the challenge of a “difficult” substrate still manages to
ubiquitinate and degrade misfolded proteins.
Attempts to conclusively characterize the type of bond
formed between a serine or threonine residue and ubiquitin
have proved to be challenging in this study and elsewhere.
Given the large number of possible ubiquitin acceptor sites,
the potential for distributedmultiubiquitination is quite high.
Furthermore, there is a strong probability that alternative
residues compensate when primary ubiquitination sites are
rendered unusable by site-directed mutagenesis. With that
said, ubiquitination of KR-TCR𝛼 is not completely eliminated
by alkaline hydrolysis (Figure S3). While it is formally possi-
ble that structural features somehow protect these linkages
from hydrolysis, the result of this experiment combined with
the absence of evidence for a Ser/Thr linked ggSP argues that
the ubiquitin linkage to TCR𝛼 may not actually be solely
through the predicted ester linkage. Of particular concern
is that despite SILAC evidence indicating that the majority
of VAGFNLLMTLR is modified, no ggSP were detectable
for Thr-262 in KR-TCR𝛼. It remains possible that ubiquitin
is bound to Thr-262 through another partially hydrolyzable
bond. Another possibility remains that a secondary “carrier”
of ubiquitin is covalently bound to KR-TCR𝛼 via threonine
and that this carrier-KR-TCR𝛼 bond is itself partially sus-
ceptible to alkaline hydrolysis. Whether this “carrier” exists
and, moreover, whether it is proteinaceous or not remains to
be determined. Examination of identified proteins between
vector transfected cells and cells expressing KR-TCR𝛼 did not
reveal any obvious candidates, although additional studies are
required. It is potentially noteworthy that Ub-like proteins
in the autophagy pathway have been shown to conjugate
membrane bound lipids directly [22]. Lastly, this peptidemay
be additionallymodified on another amino acid confounding
our ability to identify the ubiquitinated form. Defining the
exact chemical composition of nonlysine ubiquitination may
require a more refined substrate and/or new algorithms
designed to search for peptides with unexpected mass modi-
fications.
In conclusion, we have shown that Hrd1 can ubiqui-
tinate and degrade ERAD substrates using both conven-
tional, lysine ubiquitination and unconventional, lysine-
independent ubiquitination. Using SILAC, we have been able
to determine which lysine-less peptides are modified, even
though the nature of the ubiquitin modification is unknown.
This technology could easily be applied to other posttransla-
tional modifications, especially in cases where the chemical
composition is unclear or when multiple modifications on a
single peptide may be interfering with traditional database
search identifications.
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